4893 items matching your search terms.

Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: the ANZUP ENZAMET study

Davis, I

EVERSUN: a phase 2 trial of everolimus alternating with sunitinib as first line therapy for advanced renal cell carcinoma (ANZUP trial 0901)

Davis, ID Long, A Martin, A Espinoza, D Yip, S Kichenadasse, G Thompson, JF Harrison, ML Lowenthal, RM Pavlakis, N Azad, A Kannourakis, G Steer, C Goldstein, D Shapiro, JD Stockler, MR Australian & New Zealand Urogenital and Prostate Cancer Trials Group,

EVERSUN: A phase 2 trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (ANZUP Trial 0901)

Davis, ID Long, A Martin, A Espinoza, D Yip, S Thompson, JF Kichenadasse, G Harrison, M Lowenthal, RM Pavlakis, N Azad, A Kannourakis, G Steer, C Goldstin, D Shapiro, J Stockler, MR Australian & New Zealand Urogenital and Prostate Cancer Trials Group,
, 2014     DOI:10.1016/j.ejca.2014.03.255

Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: ENZAMET (ANZUP 1304)

Davis, I Stockler, M Martin, A Long, A Yip, S Coskinas, X Sweeney, C
, 2014     DOI:10.1093/annonc/mdu336.51

EVERSUN: A phase 2 trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (ANZUP Trial 0901)

Davis, I.D. Long, A. Martin, A. Espinoza, D. Yip, S. Thompson, J.F. Kichenadasse, G. Harrison, M. Lowenthal, R. M. Pavlakis, N. Azadg, A. Kannourakish, G. Steer, C. Goldstein, D. Shapiro, J. Stockler, M.R. Australian & New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),
, 2014     DOI:10.1016/j.ejca.2014.03.255

Senior work-up assessment and treatment team in an emergency department: a randomised control trial

Davis, R. A. Dinh, M. M. Bein, K. J. Veillard, A. S. Green, T. C.
EMERGENCY MEDICINE AUSTRALASIA, 2014     DOI:10.1111/1742-6723.12256

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

Decensi, A. Sun, Z. Guerrieri-Gonzaga, A. Thurlimann, B. McIntosh, C. Tondini, C. Monnier, A. Campone, M. Debled, M. Schonenberger, A. Zaman, K. Johansson, H. Price, K. N. Gelber, R. D. Goldhirsch, A. Coates, A. S. Aebi, S.
BREAST CANCER RESEARCH AND TREATMENT, 2014     DOI:10.1007/s10549-014-2849-2

What is clinically relevant prolapse? An attempt at defining cutoffs for the clinical assessment of pelvic organ descent

Dietz, H.P. Mann, K.P.
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014     DOI:10.1007/s00192-013-2307-4

Peroxisome proliferatore activated receptor a protects capillary pericytes in the retina

Ding, L. Cheng, R. Hu, Y. Takahashi, Y. Jenkins, A. J. Keech, A. C. Humphries, K. M. Gu, X. Elliott, M. H. Xia, X. May, J. X.
AMERICAN JOURNAL OF PATHOLOGY, 2014     DOI:10.1016/j.ajpath.2014.06.021

Refining the trauma triage algorithm at an Australian major trauma centre: derivation and internal validation of a triage risk score

Dinh, M. M. Bein, K. J. Oliver, M. Veillard, A. S. Ivers, R.
EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2014     DOI:10.1007/s00068-013-0315-1

Benefit of treatment of latent tuberculosis infection in individual patients: a decision aid

Dobler, CC Martin, A Marks, GB

Adjusted risk difference estimation using a stable and flexible method for additive binomial models

Donoghoe, M.W. Marschner, I.C.

Smooth semi-parametric adjustment of rate differences, risk differences and relative risks

Donoghoe, M.W. Marschner, I.C.

Stable computational methods for additive binomial models with application to adjusted risk differences

Donoghoe, M.W. Marschner, I.C.

The relationship between EGFR and KRAS mutation status and overall survival in the NCIC CTG BR.26 randomized trial of dacomitinib versus placebo in patients with previously treated non small cell lung cancer

Ellis, P Liu, G Millward, M Perrone, F Shepherd, F Seymour, L Sun, S Cho, B Morabito, A Stockler, M Leighl, N Lee, C Wierzbicki, R Favaretto, A Taso, M Wilson, CF Taylor, I Ding, K Goss, G Bradbury, PA
, 2014     DOI:10.1093/annonc/mdu349.91